Brandon May of Clinical Pain Advisor discusses updated evidence-based recommendations for Buprenorphine treatment. See the full article here.

Comments from the owner:

This extensive review article makes several blockbuster recommendations for opioid addiction treatment based on long-term patient outcomes. It also supports many notions long suspected by practitioners who prescribe buprenorphine products. First, the meds are very safe. Second, they are safe to use even in combination with judiciously prescribed benzodiazepines. Third, it is clearly the buprenorphine itself that is of primary importance in preventing relapse, not behavioral therapy. This is consistent with the belief that for behavioral health to be useful in selected patients, the patient must first have cravings and urges controlled by buprenorphine. Fourth, ‘abstinence only’  programs are destined to fail for the vast majority of patients.